Clinical Trial Update: Southeast Asia Dose Optimization of Tafenoquine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in Southeast Asia is evaluating dose optimization of tafenoquine for Plasmodium vivax malaria and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: University of Oxford | Conditions: Plasmodium Vivax Malaria | Phase 4 | Status: RECRUITING